TOBRAMYCIN 0.3% EYE DROP
For 5 mL
Pharmacies pay
$5.54 filed
5 × $1.1081 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$11.37 estimated
$5.54 + $0.83 (15%) + $5.00 fee per fill = $11.37
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
TOBRAMYCIN 0.3% EYE DROP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “tobramycin” and “tobramycin ophthalmic solution”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as “solution” and “solution/ drops” and its route as ophthalmic.
FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Bausch & Lomb Incorporated, Sandoz Inc and Alembic Pharmaceuticals Inc.
FDA’s Established Pharmacologic Class for it is Aminoglycoside Antibacterial.
The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $5.54 for 5 mL (5 × $1.1081 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
What NADAC measures · NADAC explanation codes
All 4 NDCs
- 24208-0290-05 · Bausch & Lomb Incorporated · $1.1081 per ML · eff. 2026-09-23 filed
- 61314-0643-05 · Sandoz Inc · $1.1081 per ML · eff. 2026-09-23 filed
- 62332-0518-05 · Alembic Pharmaceuticals Inc. · $1.1081 per ML · eff. 2026-09-23 filed
- 70069-0131-01 · Somerset Therapeutics, LLC · $1.1081 per ML · eff. 2026-09-23 filed
Other strengths, forms and brands
3 other products in the NADAC file share an FDA nonproprietary name with TOBRAMYCIN 0.3% EYE DROP.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| TOBRAMYCIN 0.3% EYE DROP this page | $1.1081 per ML filed | We don’t know yet |
| TOBRAMYCIN 80 MG/2 ML VIAL | $0.83153 per ML filed | $1.1725 per ML derived |
| TOBRAMYCIN 300 MG/5 ML AMPULE | $1.084 per ML filed | $2.2808 per ML derived |
| TOBREX 0.3% EYE OINTMENT | $84.41452 per GM filed | $74.4502 per GM filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Compared with its class
The middle of its 4 NDCs’ NADAC prices is $1.1081 per ML filed.
Of the 15 other products in FDA’s Aminoglycoside Antibacterial class priced per ML, 12 have a higher middle NADAC price and 3 a lower one. The one in the middle is TOBRAMYCIN-DEXAMETH OPHTH SUSP, at $4.1784 per ML filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 5 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 5 mL; your package may hold a different amount.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 5 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 5 mL in one package for all 4 NDCs of this product (“1 BOTTLE, DROPPER in 1 CARTON (24208-290-05) / 5 mL in 1 BOTTLE, DROPPER”), so the card starts at one package: 5 ML. Change it to match your prescription.
Related pages
Its pharmacologic class
Related in the same class
- TOBRAMYCIN-DEXAMETH OPHTH SUSP
- NEOMYCIN 500 MG TABLET
- TOBRADEX ST 0.3-0.05% EYE DROP
- AMIKACIN SULF 500 MG/2 ML VIAL
- CORTISPORIN-TC EAR SUSPENSION